b'Sun Pharma Taiho OncologySun Pharma is the fourth largest specialtyThe mission of Taiho Oncology, Inc. is to improve generic pharmaceutical company in the worldthe lives of patients with cancer, their families with global revenues of over U.S. $5 billion.and their caregivers. The company specializes in Supported by more than 40,000 employees the development and commercialization of orally and 43 manufacturing facilities, we provideadministered anticancer agents for various tumorhigh-quality medicines, types. Taiho Oncology has a robust pipeline of trusted by healthcare small molecule clinical candidates targeting professionals and patients, solid tumor and hematological malignancies, to more than 100 countries with additional candidates in pre-clinical across the globe. Over the development. Taiho Oncology is a subsidiary of last two decades, Sun Pharma has establishedTaiho Pharmaceutical Co., Ltd. which is part of itself as a leading player in the U.S. genericsOtsuka Holdings Co., Ltd. Taiho Oncology market, and we are rapidly ramping up ouris headquarteredpresence in the specialty branded market. in Princeton,For further information, please visit www. New Jersey andsunpharma.com. oversees its parent companys European andCanadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. See our ads on pages 131 and 147. Questions, contact Nick Edwards, nedwards@taihooncology.comSee our ad on page 108.THEDIRECTORY ADVERTISING GUIDE'